검색
검색 팝업 닫기

Ex) Article Title, Author, Keywords

Article

review

Pharmacoepidemiology and Risk Management 2024; 16(2): 100-112

Published online September 30, 2024 https://doi.org/10.56142/perm.24.0010

Copyright © Korean Society for Pharmacoepidemiology and Risk Management.

Translation of HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects: A Good Practices Report of a Joint ISPE/ISPOR Task Force

치료 효과에 대한 실사용증거 연구의 가설 평가 재현성을 높이기 위한 조화된 연구계획서 양식: 국제약물역학회와 국제약물경제성평가 및 성과연구학회 공동 태스크포스의 모범 사례 보고서

Suvin Park1, Hee-Jin Kim1, Haerin Cho1, Jeong Ah Kim1, Hui-Eon Lee2, Heehyun Won1, Ye-Jee Kim3,4, Ju-Young Shin5,6,7, Joongyub Lee8, Nam-Kyong Choi1,2

박수빈1, 김희진1, 조해린1, 김정아1, 이희언2, 원희현1, 김예지3,4, 신주영5,6,7, 이중엽8, 최남경1,2

1Department of Health Convergence, College of Science and Industry Convergence, Ewha Womans University, Seoul, Korea
2Graduate School of Industrial Pharmaceutical Science, College of Pharmacy, Ewha Womans University, Seoul, Korea
3Department of Clinical Epidemiology and Biostatistics, Asan Medical Center, Seoul, Korea
4Department of Digital Medicine, University of Ulsan College of Medicine, Seoul, Korea
5School of Pharmacy, Sungkyunkwan University, Suwon, Korea
6Department of Biohealth Regulatory Science, Sungkyunkwan University, Suwon, Korea
7Samsung Advanced Institute for Health Sciences and Technology, Sungkyunkwan University, Seoul, Korea
8Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea

1이화여자대학교 신산업융합대학 융합보건학과, 2이화여자대학교 약학대학 제약산업학과, 3서울아산병원 의학통계학과, 4울산대학교 의과대학 디지털의학교실, 5성균관대학교 약학대학, 6성균관대학교 바이오헬스규제과학과, 7성균관대학교 삼성융합의과학원, 8서울대학교 의과대학 예방의학교실

Correspondence to:Nam-Kyong Choi
Department of Health Convergence, Ewha Womans University, 52 Ewhayeodae-gil, Seodaemun-gu, Seoul 03760, Korea
Tel: +82-2-3277-6585
Fax: +82-2-3277-2867
E-mail: nchoi@ewha.ac.kr

Received: March 12, 2024; Revised: May 26, 2024; Accepted: May 28, 2024

This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Reproducibility and transparency are fundamental scientific principles that enhance research efficiency, facilitate corrections, and strengthen the reliability of published literature. The clearer each stage of the research process is, the easier it is for reviewers to understand how evidence was obtained and to evaluate the validity of the methods used. This also helps in understanding differences between studies addressing similar topics. A recent evaluation has revealed significant discrepancies in the transparency of real-world evidence (RWE) studies, emphasizing the need for rigorous and internationally agreed-upon guidelines. To address this issue, the International Society for Pharmacoepidemiology (ISPE) and the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) have formed a joint task force with key stakeholders to develop a harmonized protocol template for RWE studies, aimed at assessing treatment effects and guiding decision-making. The HARmonized Protocol Template to Enhance Reproducibility (HARPER) incorporates various sections, guidelines, and structures from four protocol templates developed by multiple stakeholders and international organizations for RWE studies, which have been thoroughly evaluated, integrated, and updated. HARPER assists in building a common understanding of intended scientific decisions through a unified format of text, tables, and visuals. To assist Korean researchers in developing clearer and more reproducible research designs, we present the development process and usage guidelines of the HARPER format, along with the final version template, all translated into Korean from the original English publication.

KeywordsProtocol, Real world evidence, Reproducibility, Transparency

Korean Society for Pharmacoepidemiology and Risk Management

Vol.16 No.2
September, 2024

eISSN 2982-5954

Frequency: Bimonthly

Current Issue   |   Archives

Supplementary File

Stats or Metrics

Share this article on :

  • line